Trademarkia Logo

Canada

C$
Trademark Search in Canada
HARVEST ONE

View On IC.GC.CA

HARVEST ONE
WITHDRAWN BY OWNER

on 1 Nov 2022

Last Applicant/ Owned by

HARVEST ONE CANNABIS INC.

Suite 404 - 999 Canada PlaceVancouver

BRITISH COLUMBIA

CA

V6C3E2

Serial Number

1879433 filed on 24th Jan 2018

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

CA

V6C2B5

HARVEST ONE

Trademark usage description

consumer products containing cannabis, namely, cannabis oil for cosmetic purposes; cannabis preparations in the form of personal care preparations for Read More

Classification Information

Class [003]
Consumer products containing cannabis, namely, cannabis oil for cosmetic purposes; cannabis preparations in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves; cosmetics with cannabinoid content

Classification kind code

11

Class [005]
Pharmaceutical preparations for the relief of pain and treatment nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals containing cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes; pharmaceuticals, nutraceuticals, cannabinoids and cannabis compounds, namely, Cannabigerols, Cannabichromenes, Cannabidiol, Tetrahydrocannabinol, Cannabinol, Cannabinodiol, cannabicyclol, cannabielsoin, and cannabitriol for medical purposes; cannabis products, namely medicines, namely medicinal dried cannabis, and medicines containing a tetrahydrocannabinol extract, namely tetrahydrocannabinol [THC] oil for medical purposes, for clinical studies; cannabinoids and cannabis compounds, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene, for use in pharmaceuticals; medicines containing a tetrahydrocannabinol extract, namely tetrahydrocannabinol for medical purposes; cannabis based pharmaceuticals for the relief of pain and treatment of nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; cannabis products, namely, dried cannabis and dried hashish for medical use; synthetic narcotics for medical use; nutritional and dietary supplements for general health and well-being; pharmaceutical preparations for the relief of pain and treatment of nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, antineoplastic properties, and atherosclerosis; pharmaceutical preparations containing cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes; medicines containing a tetrahydrocannabinol extract; medicines derived from cannabis , namely medicinal cannabis for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; dried medical marijuana

Classification kind code

11

Class [016]
Cards, namely membership and medical identification cards; cards for use in connection with customer loyalty, reward, bonus point, and discount programs

Classification kind code

11

Class [029]
Consumer products containing cannabis, namely, cannabis oil for food, edible cannabis oil for food

Classification kind code

11

Class [030]
Consumer products containing cannabis, namely, brownies and chocolate bars infused with cannabis

Classification kind code

11

Class [031]
Plant seeds, namely agricultural seeds; cannabis products, namely cannabis seeds; cannabis plants

Classification kind code

11

Class [034]
Dried cannabis; cannabis products, namely dried hashish for smoking, dried cannabis, dried marijuana

Classification kind code

11

Class [035]
Mail order medical marihuana clubs; membership services, namely the operation and maintenance of a membership organization for retail and wholesale stores in the field of medical marihuana; retail and wholesale sales of medical marihuana and cannabis seeds; retail and wholesale store reward program; sale of medical marihuana and cannabis extracts; sale of medical marihuana and cannabis extracts, namely hashish and cannabis resins; retail and wholesale sales of cannabis; providing identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; providing medical marihuana, namely providing the retailing and wholesaling of medical marihuana

Classification kind code

11

Class [036]
Investment of funds; investment of funds in the field of cannabis and medical marijuana; capital investment; capital investment in the field of cannabis and medical marijuana; services rendered in connection with the provision of commercial financing, namely financing of purchases

Classification kind code

11

Class [040]
Assembly of pharmaceuticals for others

Classification kind code

11

Class [042]
Research services in the field of cannabis and medical marihuana; product development services in the field of cannabis and medical marihuana; developing and producing, namely development of pharmaceutical preparations and medicines; developing, producing pharmaceuticals and pharmaceutical products, namely development of pharmaceuticals and pharmaceutical products containing cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes; development of cannabis products, namely cannabis, medicines, and medicines containing a tetrahydrocannabinol extract, for clinical studies; research services, namely research of new products for others; research services in the area of cannabis namely marihuana; research services in the area of cannabis namely medical marihuana; product development services; product development services in the area of cannabis; product development services in the area of cannabis namely marihuana; product development services in the area of cannabis namely medical marihuana; providing research information in the field of marijuana and cannabis via a website; developing, producing pharmaceuticals, namely development of pharmaceutical preparations and medicines containing cannabinoids or cannabis compounds; distributing pharmaceuticals and pharmaceutical products, namely development of pharmaceuticals and pharmaceutical products containing cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes

Classification kind code

11

Class [044]
Dispensing cannabis products, namely hashish, cannabis, cannabis seeds, pharmaceuticals and nutraceuticals containing cannabis, cannabinoids and cannabis compounds; dispensing medical cannabis; dispensing medical marihuana; breeding, growing and processing, namely cultivation, harvesting and production, of cannabis; operation of a dispensary for dried cannabis and pharmaceuticals, nutraceuticals containing cannabis, cannabinoids and cannabis compounds; online operation of a dispensary for dried cannabis and pharmaceuticals, nutraceuticals containing cannabis, cannabinoids and cannabis compounds; operation of a computer database in the field of medical marihuana; distributing pharmaceuticals, namely dispensing of pharmaceutical preparations and medicines; dispensing pharmaceuticals; distributing pharmaceuticals, namely dispensing of pharmaceutical preparations and medicines containing cannabinoids or cannabis compounds; dispensing pharmaceuticals containing cannabinoids or cannabis compounds; distributing pharmaceuticals and pharmaceutical products, namely dispensing of pharmaceuticals and pharmaceutical products containing cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes and nutraceuticals; dispensing medicinal marijuana and cannabis based products, namely cannabis based pharmaceuticals and nutraceuticals; providing information in the field of medical marijuana via a website

Classification kind code

11

Class [045]
Providing online social networking services via a website

Classification kind code

11

Mark Details

Serial Number

1879433

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 23
on 11th Aug 2020		Default Removed
Submitted for opposition 135
on 23rd Jun 2020		Amendment to Application
Submitted for opposition 14
on 3rd Mar 2020		Default Notice Sent
Submitted for opposition 135
on 19th Feb 2020		Amendment to Application
Submitted for opposition 12
on 16th May 2019		Extension of Time
Submitted for opposition 22
on 25th Oct 2018		Search Recorded
Submitted for opposition 20
on 25th Oct 2018		Examiner's First Report
Submitted for opposition 31
on 30th Jan 2018		Formalized
Submitted for opposition 1
on 25th Jan 2018		Created
Submitted for opposition 30
on 24th Jan 2018		Filed